Why direct compression lactose matters in modern drug development
The pharmaceutical industry faces increasing pressure to shorten development timelines, improve product quality, and reduce manufacturing costs. DC lactose supports these objectives by:
- Enabling simpler manufacturing – Eliminates wet granulation steps, reducing processing time and equipment needs.
- Enhancing formulation robustness – Offers consistent particle size distribution and mechanical properties for better tablet uniformity.
These benefits translate into faster scale-up, reduced production costs, and improved batch-to-batch reproducibility—key drivers for both generics and innovative drug developers.
The sustainability imperative
Sustainability is no longer a “nice to have” in pharma—it’s a requirement. Regulatory agencies, healthcare providers, and patients increasingly expect medicines to be developed and produced with reduced environmental impact. DC lactose contributes to greener manufacturing by:
- Lowering energy consumption – Fewer processing steps mean less energy usage compared to granulation.
- Reducing water usage – No wet granulation stage, which often requires significant amounts of purified water.
- Minimizing waste – Streamlined processes and improved yield reduce material loss.
In an industry where sustainability metrics are under greater scrutiny, switching to direct compression processes can help companies meet environmental targets without compromising product performance.
What Armor Pharma brings to the table
Armor Pharma offers a dedicated range of pharmaceutical-grade lactose excipients designed specifically for direct compression applications. By combining expertise in dairy processing with deep knowledge of pharmaceutical manufacturing needs, Armor Pharma provides:
- Tailored particle engineering for optimal flow and compressibility.
- Consistent quality and regulatory compliance meeting global pharmacopeia standards.
- Sustainable sourcing and manufacturing aligned with corporate responsibility goals.
- Technical support to help formulators
Whether for high-speed tableting, moisture-sensitive actives, or patient-centric dosage forms, Armor Pharma’s DC lactose portfolio offers reliable, sustainable solutions that bridge the gap between performance and environmental responsibility.
